While developments in cancer therapeutics have greatly reduced morbidity and mortality in
females with breast cancer, it comes at a cost of an increased risk of cardiovascular …

Background Prior reports on a possible female survival advantage in both surgical and
nonsurgical cohorts of patients with lung cancer are conflicting. Previously reported …

Diabetes and cancer are common, chronic, and potentially fatal diseases that frequently co-
exist. Observational studies have reported an increased risk of cancer in patients with …

Purpose Cancer survivors experience significant health concerns compared to the general
population. Sydney Survivorship Clinic (SSC) is a multi-disciplinary clinic aiming to help …

Cancer and heart failure are the two leading causes of death in developed countries. These
two apparently distinct clinical entities share similar risk factors, symptoms, and …

The main focus of cardio-oncology has been the prevention and treatment of the cardiac
toxicity of chemotherapy and radiotherapy. Furthermore, several targeted therapies have …

3 Edvinsson L. The trigeminovascular pathway: role of CGRP and CGRP receptors in
migraine. Headache 2017; 57 (suppl 2): 47–55. 4 Dodick DW, Lipton RB, Silberstein S, et al …

Abstract Purpose of Review Breast cancer therapies, such as anthracyclines, trastuzumab,
and chest irradiation, have well-established cardiotoxicities that lead to adverse outcomes …

Drug repurposing, also known as drug repositioning, entails the application of pre-approved
or formerly assessed drugs having potentially functional therapeutic amalgams for curing …

The use of chemotherapy medicines for breast cancer (BC) has been associated with an
increased risk of cardiotoxicity. In recent years, there have been growing interests regarding …